108 related articles for article (PubMed ID: 7083245)
1. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
[TBL] [Abstract][Full Text] [Related]
2. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin, vinblastine, and mitoguazone in squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study.
Chapman R; Fleming TR; Van Damme J; Macdonald J
Cancer Treat Rep; 1987 Dec; 71(12):1185-7. PubMed ID: 3690527
[TBL] [Abstract][Full Text] [Related]
4. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma.
Todd RF; Garnick MB; Canellos GP; Richie JP; Gittes RF; Mayer RJ; Skarin AT
Cancer Treat Rep; 1981; 65(1-2):17-20. PubMed ID: 7226167
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
Kelsen DP; Fein R; Coonley C; Heelan R; Bains M
Cancer Treat Rep; 1986 Feb; 70(2):255-9. PubMed ID: 3948190
[TBL] [Abstract][Full Text] [Related]
6. Methyl-GAG in patients with malignant neoplasms: a phase I re-evaluation.
Hart RD; Ohnuma T; Holland JF; Bruckner H
Cancer Treat Rep; 1982 Jan; 66(1):65-71. PubMed ID: 7053268
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of methylglyoxal-bis-(guanylhydrazone) in non-small-cell lung cancer.
Chapman R; Kelsen D; Gralla R; Itri L; Casper E; Young C; Golbey R
Cancer Clin Trials; 1981; 4(4):389-91. PubMed ID: 6274532
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Forastiere A; Arquette M; Costa F; Heelan R; Huang Y; Kelsen DP
Cancer J; 2000; 6(5):316-23. PubMed ID: 11079171
[TBL] [Abstract][Full Text] [Related]
9. Phase I-II trial of methyl-GAG: a Southwest Oncology Group Pilot Study.
Knight WA; Livingston RB; Fabian C; Costanzi J
Cancer Treat Rep; 1979; 63(11-12):1933-7. PubMed ID: 526927
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
[No Abstract] [Full Text] [Related]
12. Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
Yap HY; Blumenschein GR; Schell F; Bodey GP
Cancer Treat Rep; 1981; 65(5-6):465-7. PubMed ID: 7237467
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
Fuks JZ; Van Echo DA; Aisner J; Mitchell EP; Woolley PV; Wiernik PH
Cancer Clin Trials; 1981; 4(4):411-4. PubMed ID: 7318123
[TBL] [Abstract][Full Text] [Related]
14. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for esophageal cancer with mitoguazone, methotrexate, bleomycin, and cisplatin.
Vogl SE; Camacho F; Berenzweig M; Ruckdeschel J
Cancer Treat Rep; 1985 Jan; 69(1):21-3. PubMed ID: 2578314
[TBL] [Abstract][Full Text] [Related]
16. Vindesine in the treatment of esophageal carcinoma: a phase II study.
Kelsen DP; Bains M; Cvitkovic E; Golbey R
Cancer Treat Rep; 1979; 63(11-12):2019-21. PubMed ID: 526935
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
Thongprasert S; Bosl GJ; Geller NL; Wittes RE
Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
[No Abstract] [Full Text] [Related]
18. [Phase II study of paclitaxel and cisplatin for advanced squamous-cell carcinoma of esophagus].
Huang J; Cai RG; Meng PJ; Zhang MJ; Cui CX; Yang L; Chu DT; Sun Y; Wang JW
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):753-5. PubMed ID: 15733398
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
Kelsen DP; Bains M; Chapman R; Golbey R
Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
